Non disponible en dehors du Royaume-Uni et de l'Irlande
Biochem/physiol Actions
CGP3466B, also known as Omigapil maleate and TCH346, is a potent inhibitor of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). It has been shown to have neuroprotective activity and received U.S. FDA Fast Track Designation for the treatment of congenital muscular dystrophy in May 2016.
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :